Physician profile
Hector Flores
NPI 1124070578
$652.71
in general payments reported to CMS, 2019-2025
12 companies · $20.10 in 2025
The $20.10 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $48.89 · 2021: $22.00 · 2022: $170 · 2023: $66.64 · 2024: $149 · 2025: $20.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $164.77 | 2019-2023 | |
| Genzyme Corporation | $125.00 | 2024 | |
| Janssen Biotech, INC. | $121.04 | 2019 | |
| Abbvie INC. | $48.84 | 2020-2023 | |
| Glaxosmithkline, LLC. | $45.93 | 2021-2024 | Bexsero |
| Radius Health, INC. | $25.12 | 2020 | |
| Sanofi-Aventis U.S. LLC | $24.19 | 2022 | |
| Abbott Laboratories | $24.12 | 2022 | |
| Merck Sharp & Dohme LLC | $20.83 | 2022 | |
| Novo Nordisk INC | $20.10 | 2025 | Ozempic, Rybelsus |
| Phadia US INC. | $17.36 | 2019 | |
| Amgen INC. | $15.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.